NCT04387851
- Conditions
- Itch, Neurologic Manifestations, Pain, +6 more
- Locations
-
- Leiden University Leiden, South Holland, Netherlands
Clinical trial condition
Pruritus
Explore clinical trials studying Pruritus. Study availability and eligibility vary by location and protocol.
331 public trials
35 recruiting studies
Pruritus trial results
NCT05094687
- Conditions
- Bacterial Infections and Mycoses, Blood Coagulation Disorders, COVID-19, +72 more
- Locations
-
- Jinnah Postgraduate Medical Centre Karachi, Sindh, Pakistan
NCT04557644
- Conditions
- Contagious Itch, Ectoparasitic Infestations, Infections, +11 more
- Locations
-
- Department of Dermatology; University Hospital Basel Basel, Switzerland
NCT03998163
- Conditions
- Chronic Disease, Disease Attributes, Female Urogenital Diseases, +16 more
- Locations
-
- Cara Therapeutics Study Site Escondido, California, United States
- Cara Therapeutics Study Site Riverside, California, United States
- Cara Therapeutics Study Site San Diego, California, United States
- Cara Therapeutics Study Site Victorville, California, United States
Completed
Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
NCT03281538
- Conditions
- Chronic Disease, Disease Attributes, Female Urogenital Diseases, +16 more
- Locations
-
- Cara Therapeutics Study Site Chula Vista, California, United States
- Cara Therapeutics Study Site El Centro, California, United States
- Cara Therapeutics Study Site Long Beach, California, United States
- Cara Therapeutics Study Site Northridge, California, United States
NCT03504852
- Conditions
- Body Weight, Moderate to Severe Chronic Plaque-Type Psoriasis, Pathological Conditions, Anatomical, +9 more
- Locations
-
- Novartis Investigative Site Birmingham, Alabama, United States
- Novartis Investigative Site Phoenix, Arizona, United States
- Novartis Investigative Site Rogers, Arkansas, United States
- Novartis Investigative Site Irvine, California, United States
Completed
Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab
NCT03553823
- Conditions
- Chronic Plaque-type Psoriasis, Pathological Conditions, Signs and Symptoms, Pruritus, +6 more
- Locations
-
- Novartis Investigative Site New Orleans, Louisiana, United States
- Novartis Investigative Site East Windsor, New Jersey, United States
- Novartis Investigative Site Philadelphia, Pennsylvania, United States
- Novartis Investigative Site Dallas, Texas, United States
NCT04745429
- Conditions
- Behavior, Behavioral Symptoms, Depression, +20 more
- Locations
-
- Medical Univeristy of Lodz, Chair of Clinical Immunology and Rheumatology Lodz, Łódź Voivodeship, Poland
NCT03483870
- Conditions
- Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, +3 more
- Locations
-
- Assiut University Hospital Asyut, Egypt
NCT03824886
- Conditions
- Dermatitis, Dry Skin, Incontinence-associated Dermatitis, +13 more
- Locations
-
- Charité - Universitätsmedizin Berlin Berlin, Germany
- Charité-Universitätsmedizin Berlin Berlin, Germany